This is an abnormal, involuntary movement problem caused by taking certain medications, like some antipsychotic drugs. It can cause strange movements in your face, tongue, or body. It's important to talk to your doctor if you think you might be experiencing this.
Every report comes from a Lived member, sent anonymously.
Have you tried Ingrezza (Valbenazine) for Drug-Induced Dyskinesia?
Drug-induced dyskinesia means abnormal, involuntary movements caused by a medicine. The movements can be repetitive twitches or grimaces, slow writhing, sustained muscle spasms, stiffness and slowness, or a restless need to keep moving. They most often involve the face, mouth, neck, trunk and limbs, and they can affect eating, speaking and how comfortable someone feels around other people. Several distinct problems fall under this label, and telling them apart matters because each has its own timing, course and treatment. Acute dystonia is a sudden, often painful muscle spasm that can twist the neck, clench the jaw or pull the eyes upward, usually within hours to days of starting or raising a medicine. Drug-induced parkinsonism causes slowness, stiffness and tremor that resemble Parkinson's disease. Akathisia is an intense inner restlessness that makes it hard to sit still. Tardive dyskinesia (tardive means delayed) appears after months or years of treatment, typically as lip smacking, chewing motions, tongue movements or frequent blinking, and it can be permanent. People with Parkinson's disease can develop a separate form, levodopa-induced dyskinesia, after years on their main medicine.
Most drug-induced movement problems come from medicines that block dopamine, a chemical messenger the brain uses to produce smooth, controlled movement. Antipsychotics, which treat schizophrenia, bipolar disorder and several other conditions, are the most common cause. Metoclopramide, a medicine for nausea and slow stomach emptying, is another well-known cause and carries a US Food and Drug Administration (FDA) boxed warning, the agency's most prominent label warning, about tardive dyskinesia. Older (first-generation) antipsychotics carry more risk than newer ones, but newer ones are not free of it: one review estimates that about 30% of people taking older antipsychotics and 20% taking newer ones have tardive dyskinesia. For tardive dyskinesia, risk grows with longer treatment and higher total doses. Older age, female sex, diabetes, substance use and a previous drug-induced movement problem also raise the risk. Acute dystonia follows a different pattern: it is more likely in younger people and in males, with injected medicines and with high doses of strong older antipsychotics. These are risk factors, not certainties, and many people take these medicines for years without developing a movement disorder. Levodopa-induced dyskinesia arises differently. In Parkinson's disease, long-term levodopa treatment and the progressing disease together lead to abnormal dopamine signaling that spills over into extra movement. About a quarter of people develop it after years of levodopa.
Diagnosis rests on a clinician watching the movements and matching them to the medication history. The kind of movement and when it began, relative to starting, increasing, lowering or stopping a medicine, usually point to which disorder is present. A complete list of current and recent medicines, including anti-nausea drugs taken only now and then, is essential. Because some forms can become permanent, guidelines recommend that anyone taking an antipsychotic be checked for abnormal movements at every visit. A standardized rating exam such as the Abnormal Involuntary Movement Scale (AIMS) is recommended at least once a year, or every six months for people at higher risk, such as older adults. Comparing results over time shows whether movements are appearing or changing. Some forms are easy to mistake for something else. Akathisia can look like anxiety, and raising an antipsychotic dose in response can make it worse, so it helps to describe the feeling as an urge to move rather than worry. Persistent parkinsonism may also reveal Parkinson's disease that a medicine has unmasked, which a clinician may need to assess separately.
Treatment depends on which movement disorder is present, and it starts with a review of the medicine responsible. Do not stop or lower an antipsychotic on your own: reducing the dose can temporarily make movements worse and can bring back psychiatric symptoms, so any change is planned with the prescriber. When metoclopramide is the cause of tardive dyskinesia, it is usually stopped. Acute dystonia generally eases rapidly after an injection of diphenhydramine or benztropine, medicines with anticholinergic effects. A tablet form may be continued for a short time while the medicine plan is adjusted. Drug-induced parkinsonism and akathisia often improve when the dose is lowered or the medicine is switched. In the meantime, amantadine or a short course of an anticholinergic can help parkinsonism, although anticholinergics can affect memory and thinking, particularly in older adults. For akathisia, options include propranolol (a beta blocker), low-dose mirtazapine (an antidepressant) or a benzodiazepine (a calming medicine). For tardive dyskinesia, two medicines are FDA-approved for adults: valbenazine (Ingrezza) and deutetrabenazine (Austedo, also available as Austedo XR). Both are VMAT2 (vesicular monoamine transporter 2) inhibitors, thought to work by limiting how nerve cells store and release dopamine and related messengers. In trials they reduced movements more than placebo, and they can be taken while continuing a needed psychiatric medicine. Guidelines suggest them for moderate to severe tardive dyskinesia, or for milder cases that are bothersome or interfere with daily life. Sleepiness is common, both can cause Parkinson-like stiffness, and deutetrabenazine is not used in people with untreated depression or active suicidal thoughts. Anticholinergics such as benztropine do not help tardive dyskinesia and may worsen it. Switching or stopping an antipsychotic has not been shown to reliably treat it. In Parkinson's disease, levodopa-induced dyskinesia is managed by adjusting Parkinson's medicines, balanced against the return of stiffness and slowness. Extended-release amantadine (Gocovri) is approved for it; hallucinations, dizziness, falls and ankle swelling are among its common side effects. Deep brain stimulation, a surgery that places electrodes in movement-control areas of the brain, can reduce dyskinesia and the amount of levodopa needed in advanced cases.
The outlook differs a great deal by type. Acute dystonia usually resolves quickly with treatment, and the focus afterward is preventing a repeat while the medicine plan changes. Drug-induced parkinsonism and akathisia usually fade after the medicine is reduced or switched, although recovery can take weeks to months, especially in older adults. In a minority of people with parkinsonism (up to about 15%), symptoms persist, sometimes because Parkinson's disease was already developing. Tardive dyskinesia is more often long-lasting. Movements may lessen, partially or completely, after the responsible medicine is stopped, but many people need to keep taking it, and the condition can be permanent. Full recovery after stopping is the exception rather than the rule. The movements are often visible to others: in surveys, about half of people with tardive dyskinesia felt self-conscious or embarrassed, and some had trouble chewing, eating or speaking. Treatment with a VMAT2 inhibitor does not cure the condition but can make movements less intrusive. Follow-up involves regular movement exams to track change, check that treatment is helping and watch for side effects. For people who need an antipsychotic long term, the aim is to balance control of their mental health condition with keeping movement problems as small as possible.
Contact your prescriber soon if you notice, or someone points out, repetitive movements of the lips, tongue, jaw, face or fingers while taking an antipsychotic or metoclopramide, or if an existing movement problem changes. Early recognition gives the best chance of limiting tardive dyskinesia. Get same-day medical care for new muscle spasms (a twisted neck, clenched jaw or eyes stuck looking upward), sudden stiffness or tremor, or overwhelming restlessness after starting or increasing one of these medicines. Call 911 if a spasm affects the throat and makes breathing or swallowing difficult.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Drug-Induced Dyskinesia is like, what's helped you, or ask the community a question.